Skip to content

Clinical research

Clinical trial sites in Asia-Pacific

Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.

  • Trial site
  • Group of pins (click to zoom)

Showing the 40,000 busiest of 156,891 located sites. The map holds only the first 40,000, so narrow the filters to see the rest.

Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.

Looking for contract research suppliers and CROs? Visit Contract Research Map

Looking to track new and ongoing clinical trials? Visit Trial Insights

Filters: Region: Asia-Pacific Clear all

Trial sites by region

Select a bar to filter by region.

Scale
Trial sites by region
CategoryTrial sites
Europe474,077
North America335,544
Asia-Pacific156,891
Latin America45,783
Africa19,488
Middle East14,332
Other3,142

Top countries

Country of the site's address. Select a bar to filter.

Scale

Bar colour shows the country's region, as in the chart by region.

Trial sites by country
CategoryTrial sites
China45,975
Japan38,756
Australia16,431
South Korea13,476
India12,730
Taiwan6,734
Pakistan3,805
Thailand3,352

Trial sites

156,891 sites. Sites with a public page link to it on Pharma Observatory.

  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukui, Japan 9 trials
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kochi, Japan 9 trials
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China Ongoing trial 9 trials
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pusan, South Korea 9 trials
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Busan, South Korea 9 trials
  • Fremantle Hospital Fremantle, Australia Ongoing trial 9 trials
  • Fudan University Affiliated Huashan Hospital Shanghai, Shanghai Municipality, China Ongoing trial 9 trials
  • Fukui-ken Saiseikai Hospital Fukui, Japan 9 trials
  • Funabashi Municipal Medical Center Funabashi, Chiba, Japan Ongoing trial 9 trials
  • Fuwai Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China Ongoing trial 9 trials
  • GSK Investigational Site Camberwell, Victoria, Australia Ongoing trial 9 trials
  • GSK Investigational Site Blacktown, New South Wales, Australia Ongoing trial 9 trials
  • GSK Investigational Site Suzhou, Jiangsu, China 9 trials
  • GSK Investigational Site Concord, New South Wales, Australia 9 trials
  • GSK Investigational Site Spearwood, Western Australia, Australia Ongoing trial 9 trials
  • GSK Investigational Site Shiga, Japan Ongoing trial 9 trials
  • GSK Investigational Site Pasay, Philippines 9 trials
  • GSK Investigational Site Tuenmen, Hong Kong 9 trials
  • GSK Investigational Site Shijiazhuang, Hebei, China Ongoing trial 9 trials
  • GSK Investigational Site Sherwood, Queensland, Australia 9 trials

Explore the data behind the map on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.